Medtronic plc — Director's Dealing 2019

Jul 31, 2019

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Medtronic plc (MDT)
CIK: 0001613103
Period of Report: 2019-07-29

Reporting Person: Kuntz Richard (SVP & Chief Medical & Science)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2019-07-29	Ordinary Shares	A	10330	—	Acquired	110755	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2019-07-29	Stock Option (Right to Buy)	$103.26	A	68901	Acquired	2029-07-29	Ordinary Shares (68901)	Direct
2019-07-29	Stock Option (Right to Buy)	$103.26	A	1615	Acquired	2029-07-29	Ordinary Shares (1615)	Direct

Footnotes

F1: The restrictions on these restricted stock units shall lapse 100% on the third anniversary of the Grant Date if the Company's cumulative non-GAAP diluted earnings per share ("EPS") growth during the 36-month period ending on the last day of the Company's fiscal year 2022 equals or exceeds a 3% cumulative compound annual growth rate, as determined by the Compensation Committee.

F2: This balance increased by 298 shares due to exempt transactions such as dividend reinvestment.

F3: These options become exercisable at the rate of 25% of the shares granted per year beginning on the first anniversary of grant.